Avanos Medical Inc. Stock News

In a report released today, Matthew Mishan from KeyBanc maintained a Buy rating on Avanos Medical (AVNS), with a price target of $45.00. The company's

In a report released today, Matthew Mishan from KeyBanc maintained a Buy rating on Avanos Medical (AVNS – Research Report),

North Star Asset Management Inc. increased its position in Avanos Medical Inc (NYSE:AVNS) by 3.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commissio

Equities analysts expect Avanos Medical Inc (NYSE:AVNS) to announce sales of $175.57 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Avanos Medical’s

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Im

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Norges Bank acquired a new position in shares of Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acq

Avanos Medical, Inc. (NYSE: AVNS) announced today that, due to the increasing public health risk posed by COVID-19 and in accordance with current governmental state of emergency orders, its 2020 Annua

Geode Capital Management LLC boosted its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities

Avanos Medical (NYSE:AVNS) was upgraded by analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued to investors on Monday, The Fly reports. The

Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (1

This week we saw the Avanos Medical, Inc. (NYSE:AVNS) share price climb by 22%. But if you look at the last five years...